Publications by authors named "Aldeguer J"

Lineage reconstruction is central to understanding tissue development and maintenance. To overcome the limitations of current techniques that typically reconstruct clonal trees using genetically encoded reporters, we report scPECLR, a probabilistic algorithm to endogenously infer lineage trees at a single-cell-division resolution by using 5-hydroxymethylcytosine (5hmC). When applied to 8-cell pre-implantation mouse embryos, scPECLR predicts the full lineage tree with greater than 95% accuracy.

View Article and Find Full Text PDF

Administration of antiretroviral drugs to individuals exposed to, but not infected by, HIV has been shown to reduce the risk of transmission. The efficacy of pre-exposure prophylaxis (PrEP) makes it obligatory to include it in an integral program of prevention of HIV transmission, together with other measures, such as use of the condom, training, counseling, and appropriate treatment of infected individuals. In this document, the AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica [SEIMC]) provides its views on this important subject.

View Article and Find Full Text PDF

In this update, antiretroviral therapy (ART) is recommended for all patients infected by type 1 human immunodeficiency virus (HIV-1). The strength and grade of the recommendation vary depending on the CD4+ T-lymphocyte count, the presence of opportunistic infections or comorbid conditions, age, and the efforts to prevent the transmission of HIV. The objective of ART is to achieve an undetectable plasma viral load (PVL).

View Article and Find Full Text PDF
Article Synopsis
  • Ritonavir-boosted lopinavir (LPV/r) is an antiretroviral treatment for HIV, is safe for patients with renal failure, and doesn't require dosage adjustments since it is metabolized in the liver.
  • Compared to other antiretroviral therapies, LPV/r shows a lower incidence of renal disease and crystalluria, making it a favorable option for patients on combination therapies.
  • LPV/r is effective in addressing neurocognitive issues associated with HIV, achieves sufficient concentrations in the cerebrospinal fluid, and while liver toxicity can occur, it is generally mild and often linked to pre-existing liver conditions.
View Article and Find Full Text PDF

Introduction: The fibrogenesis analysis in quimeric CCR1 and CCR5 mice revealed that CCR5 mediates its pro-fibrogenic effects in hepatic cells and promoting stellate cells. The blockage of co-receptors could preserve the progression of hepatic fibrosis in HIV/HCV co-infected patients.

Objective: To evaluate the beneficial effects on hepatic fibrosis in HIV/HCV co-infected patients that are on antiretroviral therapy (ART) with CCR5 co-receptor antagonists.

View Article and Find Full Text PDF